Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve Pursuant to regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biogen Pharmachem Industries Ltd has postponed its Board of Directors meeting, originally scheduled for 3rd February 2026, to Wednesday, 11th February 2026, due to unavoidable circumstances. The rescheduled meeting will, among other things, consider and approve the Un-Audited Financial Results of the Company for the quarter and nine months ended 31st December 2025 (Q3 FY26). The company (formerly known as Sun Techno Overseas Limited) has informed BSE of this change under Regulation 29(1)(d) of SEBI's LODR Regulations, 2015. The intimation has been signed by Director Kelash Bunkar.
This is a procedural update that delays the Q3 FY26 earnings announcement by about a week (from Feb 3 to Feb 11, 2026), with no change in the agenda. Shareholders should watch for the results declaration on or after 11th February 2026; near-term stock reaction is unlikely to be material unless the results surprise.